期刊文献+

阻断Ryanodine受体对兔心肌肥厚触发性室性心律失常发生的影响 被引量:2

Effect of Ryanodine receptor blockage on triggered ventricular arrhythmia in rabbits with left ventricular hypertrophy
原文传递
导出
摘要 目的:研究阻断Ryanodine受体对兔心肌肥厚触发性室性心律失常发生的影响。方法:选择日本长耳兔,通过缩窄腹主动脉建立心肌肥厚模型(LVH组),并设立假手术组(仅游离腹主动脉,不进行缩窄)作为对照。8周后应用超声心动图证实心肌肥厚形成,采用酶解法分离左室心肌细胞,应用全细胞膜片钳技术记录动作电位,观察在异丙肾上腺素(1μmol/L)灌流和快频率(5Hz)电刺激条件下,单个心肌细胞晚期后除极(DAD)和触发活动的发生率,以及预先分别灌流钙调蛋白激酶Ⅱ抑制剂KN-93(1μmol/L)和Ryanodine受体阻滞剂兰尼碱(10μmol/L)对肥厚心肌细胞DAD和触发活动发生率的影响。结果:假手术组、LVH组、KN-93组和兰尼碱组DAD的发生率分别为0、85%、35%和20%,触发活动的发生率分别为0、60%、20%和10%,KN-93组和兰尼碱组DAD和触发活动的发生率较LVH组显著降低(P<0.05)。结论:阻断Ryanodine受体能够有效抑制兔心肌肥厚触发性室性心律失常的发生,Ryanodine受体有望成为防治该类心律失常的新靶点。 Objective: 1 o investigate the ettect ot Ryanoalne receptor blockage on trlggerect ventricular arrnym mia in rabbits with left ventrieular hypertrophy (LVH). Method:Japanese rabbits were established LVH models by the coaretation of the abdominal aorta, while those in the sham group did not undergo the coarctation. After 8 weeks, single left ventricular myocyte was isolated by enzymatic dissociation method and action potential (AP) was recorded using whole cell patch clamp technique. Perfused with Tyrode's solution containing isoprenaline (1 μmol/L), the frequency of delayed afterdepolarization (DAD) and triggered activity was recorded under high- frequency stimulation stimulation (5 Hz). And the effect of KN-93 and Ryanodine perfusion on the frequency of DAD and triggered activity was observed. Result:The frequency of DAD was 0 in sham group, 85% in LVH group, 35% in KN 93 group, and 20% in Ryanodine group. The frequencies of triggered activity were 0, 60%, 20%, and 10%, respectively. The frequencies of DAD and triggered activity in KN-93 and Ryanodine groups were much lower than those in LVH group (P%0.05). Conclusion: Blockage of Ryanodine receptor is a new method of treat- ment which effectively reduce the occurrence of triggered ventricular arrhythmia in rabbits with LVH.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第3期200-203,共4页 Journal of Clinical Cardiology
基金 福建省自然科学基金面上项目(No:2008J0075) 国家自然科学基金资助项目(No:30971180)
关键词 心律失常 室性 RYANODINE受体 钙调蛋白激酶Ⅱ 晚期后除极 左室肥厚 arrhythmia, ventricular Ryanodine receptor calmodulin kinase Ⅱ delayed afterdepolarization left ventricular hypertrophy
  • 相关文献

参考文献4

二级参考文献23

  • 1王文广,张存泰,吴杰,卜军,刘念,任勇,肖志超,王琳,陆再英.钙调蛋白抑制剂对陈旧性心肌梗死兔室性心律失常的影响[J].中国心脏起搏与心电生理杂志,2005,19(1):60-62. 被引量:7
  • 2卜军,张存泰,白融,刘念,李泱,王琳.钙调蛋白拮抗剂W-7抑制索他洛尔诱发离体兔心尖端扭转型室性心动过速[J].中华心血管病杂志,2005,33(4):364-368. 被引量:12
  • 3陈灏珠.心脏病学[M].2版.北京:人民卫生出版社,2007:513.
  • 4ROSSI G, BOSCARO M, RONCONI V, et al. Aldosterone as a cardiovascular risk factor[J]. Trends Endocrinol Metab, 2005,16 : 104 -- 107.
  • 5OUVRARD-PASCAUD A, SAINTE-MARIE Y, BENITAH J P, et al. Conditional mineralocorticoid re ceptor expression in the heart leads to life-threatening arrhythmias[J]. Circulation, 2005,111 : 3025 -- 3033.
  • 6PITT B, ZANNAD F, REMME W J, et al. Randomized aldactone evaluation study investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure[J]. N Engl J Med, 1999,341:709--717.
  • 7PITT B, REMME W, ZANNAD F, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction[J].N En gl J Med,2003,348:1309-1321.
  • 8WILLIAMS J S, WILI.IAMS G H. 50th Anniversary of aldosterone[J].J Clin Endocrinol Metab,2003,88.- 2364--2372.
  • 9ROSSI G, BOSCARO M, RONCONI V, et al. Aldosterone as a cardiovascular risk factor[J]. Trends Endocrinol Metab, 2005,16 : 104-- 107.
  • 10LOUGHREY C M, MACEACHEM K E, COOPER J, et al. Measurement of dissociation constant of Fluo-3 for Ca2+ in isolated rabbit eardiomyocytes using Ca2+ wave characteristics[J]. Cell Calcium,2003,34 : 1 - 10.

共引文献8

同被引文献18

  • 1陈彦静,郝然,黄启福.参麦注射液对Ang Ⅱ诱导培养心肌细胞凋亡的影响[J].中国病理生理杂志,2004,20(9):1612-1616. 被引量:7
  • 2贾楠,戴德哉.离子通道磷酸化,心律失常和新药的靶点[J].药学进展,2007,31(1):1-8. 被引量:4
  • 3李建东,温晓竞,陈彦静,陈立锋,黄启福.参麦注射液对急性心肌梗塞大鼠心功能和心室重构的影响[J].中国中医基础医学杂志,2007,13(6):422-424. 被引量:7
  • 4Lisman J,Yasuda R,Raghavachari S. Mechanisms of CaMK Ⅱ action in long-term potentiation[J].{H}Nature Reviews Neuroscience,2012,(03):169-182.
  • 5Erickson JR,Anderson ME. CaMK Ⅱ and its role in cardiac arrhythmia[J].{H}JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY,2008,(12):1332-1336.
  • 6Curtis MJ,Walker MJ. Quantification of arrhythmias using scoring systems:an examination of seven scores in an in vivo model of regional myocardial ischemia[J].{H}Cardiovascular Research,1988,(9):656-665.
  • 7Soltis AR,Saucerman JJ. Synergy between CaMK Ⅱ Sub-strates and β-Adrenergic Signaling in Regulation of Cardiac MyocyteCa2+ Handling[J].{H}BIOPHYSICAL JOURNAL,2010,(07):2038-2047.
  • 8Dixit SS,Wang T,Manzano EJ. Effects of CaMK Ⅱ-mediated phosphorylation of ryanodine receptor type 2 on is-let calcium handling,insulin secretion,and glucose tolerance[J].PLoS One,2013,(3):e58655.
  • 9Christensen MD,Dun W,Boyden PA. Oxidized calm-odulin kinase Ⅱ regulates conduction following myocardial in-farction:a computational analysis[J].{H}PLoS Computational Biology,2009,(12):e1000583.
  • 10He BJ,Joiner ML,Singh MV. Oxidation of CaMK Ⅱdetermines the cardiotoxic effects of aldosterone[J].Nat M e d,2011,(12):1610-1618.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部